Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution
暂无分享,去创建一个
[1] C. Levinthal. Are there pathways for protein folding , 1968 .
[2] G. Glenner,et al. Creation of "Amyloid" Fibrils from Bence Jones Proteins in vitro , 1971, Science.
[3] I. Nagy,et al. Protein and water contents of aging brain. , 1982, Experimental brain research.
[4] H. Pelham. Speculations on the functions of the major heat shock and glucose-regulated proteins , 1986, Cell.
[5] O. Ptitsyn,et al. The ‘molten globule’ state is involved in the translocation of proteins across membranes? , 1988, FEBS letters.
[6] R. Ellis,et al. The molecular chaperone concept. , 1989, Biochemical Society symposium.
[7] Ellis Rj. The molecular chaperone concept. , 1990 .
[8] J. Kelly,et al. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.
[9] E. Rojas,et al. Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] E. Rojas,et al. Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] B. Yankner,et al. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Pedersen,et al. Defective protein folding as a basis of human disease. , 1995, Trends in biochemical sciences.
[13] W. Honer,et al. Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.
[14] S. Schmid,et al. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding , 1995, Nature.
[15] M. Mullan,et al. β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.
[16] B. Kagan,et al. Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*) , 1996, The Journal of Biological Chemistry.
[17] M. Mattson,et al. Aβ25–35 induces rapid lysis of red blood cells: contrast with Aβ1–42 and examination of underlying mechanisms , 1997, Brain Research.
[18] B. Kagan,et al. Channel Formation by a Neurotoxic Prion Protein Fragment* , 1997, The Journal of Biological Chemistry.
[19] M. Reilly. Genetically determined neuropathies , 1997, Journal of Neurology.
[20] Christopher M. Dobson,et al. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.
[21] D. Walsh,et al. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. , 1997, The Journal of biological chemistry.
[22] S. Aota,et al. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. , 1998, Journal of molecular biology.
[23] A K Dunker,et al. Thousands of proteins likely to have long disordered regions. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[24] T. Morgan,et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[25] I D Campbell,et al. Amyloid fibril formation by an SH3 domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Kelly,et al. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.
[27] S. Lindquist,et al. Hsp90 as a capacitor for morphological evolution , 1998, Nature.
[28] Genetic polymorphisms in Parkinson's disease. , 1998, Neurotoxicology.
[29] S. Linse,et al. Molecular Characterization of α–Lactalbumin Folding Variants That Induce Apoptosis in Tumor Cells* , 1999, The Journal of Biological Chemistry.
[30] C. Dobson. Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.
[31] J. Thyberg,et al. Amyloid fibril formation by pulmonary surfactant protein C , 1999, FEBS letters.
[32] R. Plemper,et al. Retrograde protein translocation: ERADication of secretory proteins in health and disease. , 1999, Trends in biochemical sciences.
[33] J. Kourie,et al. Synthetic mammalian C‐type natriuretic peptide forms large cation channels , 1999, FEBS letters.
[34] M Bycroft,et al. Hot-spot mutants of p53 core domain evince characteristic local structural changes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Selkoe,et al. Title Amyloid β-protein fibrillogenesis . Structure and biological activity of protofibrillar intermediates , 1999 .
[36] Christopher M Dobson,et al. From Computer Simulations to Human Disease Emerging Themes in Protein Folding , 1999, Cell.
[37] Dominic M. Walsh,et al. Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical Neurons , 1999, The Journal of Neuroscience.
[38] F. Stevens,et al. Pathogenic light chains and the B-cell repertoire. , 1999, Immunology today.
[39] H. Wiśniewski,et al. Alteration of free radical metabolism in the brain of mice infected with scrapie agent. , 1999, Free radical research.
[40] C M Dobson,et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] P. Lansbury,et al. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. , 1999, Biochemistry.
[42] Peter T. Lansbury,et al. Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .
[43] Morgan Bp. Regulation of the complement membrane attack pathway. , 1999 .
[44] B. Morgan. Regulation of the complement membrane attack pathway. , 1999, Critical reviews in immunology.
[45] A. Goldberg,et al. The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes , 1999, The Journal of Biological Chemistry.
[46] H. Dyson,et al. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. , 1999, Journal of molecular biology.
[47] M. Mattson. Impairment of membrane transport and signal transduction systems by amyloidogenic proteins. , 1999, Methods in enzymology.
[48] H. Lin,et al. Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles. , 1999, Biochemistry.
[49] Elena Orlova,et al. Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.
[50] M. Feder,et al. Natural hyperthermia and expression of the heat shock protein Hsp70 affect developmental abnormalities in Drosophila melanogaster , 1999, Oecologia.
[51] S. Prusiner,et al. Transmissible and genetic prion diseases share a common pathway of neurodegeneration , 1999, Nature.
[52] R. Lal,et al. Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity , 2000 .
[53] Jonathan W. Yewdell,et al. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes , 2000, Nature.
[54] C M Dobson,et al. Ultrastructural organization of amyloid fibrils by atomic force microscopy. , 2000, Biophysical journal.
[55] René Hen,et al. Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.
[56] P. Lansbury,et al. Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease? , 2000, Nature Cell Biology.
[57] P. Frederikse. Amyloid-like protein structure in mammalian ocular lenses. , 2000, Current eye research.
[58] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[59] Hai Lin,et al. Fresh and nonfibrillar amyloid β protein(1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP‐channel‐mediated cellular toxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] L. Serpell,et al. The protofilament substructure of amyloid fibrils. , 2000, Journal of molecular biology.
[61] M. Michalak,et al. Perforin Lytic Activity Is Controlled by Calreticulin1 , 2000, The Journal of Immunology.
[62] E. Wanker,et al. Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[63] H. Zoghbi,et al. Identification of genes that modify ataxin-1-induced neurodegeneration , 2000, Nature.
[64] H. True,et al. A yeast prion provides a mechanism for genetic variation and phenotypic diversity , 2000, Nature.
[65] L. Regan,et al. A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[66] M. Hecht,et al. Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.
[67] H. Budka,et al. Evidence for Oxidative Stress in Experimental Prion Disease , 2000, Neurobiology of Disease.
[68] T. Bek. Ocular changes in heredo-oto-ophthalmo-encephalopathy , 2000, The British journal of ophthalmology.
[69] R. Kopito,et al. Aggresomes and Russell bodies , 2000, EMBO reports.
[70] W. Markesbery,et al. Decreased levels of proteasome activity and proteasome expression in aging spinal cord , 2000, Neuroscience.
[71] W. Markesbery,et al. Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.
[72] D. F. Andrews,et al. A one-hit model of cell death in inherited neuronal degenerations , 2000, Nature.
[73] Masahiro Kawahara,et al. Alzheimer's β-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line* , 2000, The Journal of Biological Chemistry.
[74] J. Neefjes,et al. The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.
[75] A. Monji,et al. Inhibition of Aβ fibril formation and Aβ-induced cytotoxicity by senile plaque-associated proteins , 2000, Neuroscience Letters.
[76] Hyun-pil Lee,et al. Induction of heme oxygenase-1 in the brains of scrapie-infected mice , 2000, Neuroscience Letters.
[77] H. Minakata,et al. Poly-L-glutamine forms cation channels: relevance to the pathogenesis of the polyglutamine diseases. , 2000, Biophysical journal.
[78] D. Butterfield,et al. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.
[79] L. Serpell,et al. Alzheimer's amyloid fibrils: structure and assembly. , 2000, Biochimica et biophysica acta.
[80] S. Younkin,et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.
[81] M. Cheetham,et al. Unfolding retinal dystrophies: a role for molecular chaperones? , 2001, Trends in molecular medicine.
[82] Bing-sheng Li,et al. α-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway , 2001, Neuroscience Letters.
[83] D. Allsop,et al. alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. , 2001, Free radical biology & medicine.
[84] C. Dobson,et al. Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation , 2001, Protein science : a publication of the Protein Society.
[85] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[86] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[87] John Q. Trojanowski,et al. Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.
[88] C. Dobson,et al. Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. , 2001, Journal of molecular biology.
[89] H. Lehrach,et al. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. , 2001, Molecular biology of the cell.
[90] M. Spillantini,et al. α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasome , 2001, FEBS letters.
[91] M. Al-Habori,et al. Macromolecular crowding and its role as intracellular signalling of cell volume regulation. , 2001, The international journal of biochemistry & cell biology.
[92] J. Kourie,et al. Channel activity of deamidated isoforms of prion protein fragment 106–126 in planar lipid bilayers , 2001, Journal of neuroscience research.
[93] N. Cairns,et al. Deranged expression of molecular chaperones in brains of patients with Alzheimer's disease. , 2001, Biochemical and biophysical research communications.
[94] P. Csermely,et al. Chaperone overload is a possible contributor to 'civilization diseases'. , 2001, Trends in genetics : TIG.
[95] J Lowe,et al. The ubiquitin protein catabolic disorders , 2001, Neuropathology and applied neurobiology.
[96] Rui M. M. Brito,et al. Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants* , 2001, The Journal of Biological Chemistry.
[97] S. Bhakdi,et al. Membrane insertion of the heptameric staphylococcal alpha-toxin pore. A domino-like structural transition that is allosterically modulated by the target cell membrane. , 2001, The Journal of biological chemistry.
[98] H. Braak,et al. Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. , 2001, Journal of Alzheimer's disease : JAD.
[99] M. Greenberg,et al. β-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand , 2001, The Journal of Neuroscience.
[100] D. Rubinsztein,et al. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. , 2001, Human molecular genetics.
[101] Membrane Insertion of the Heptameric Staphylococcal α-Toxin Pore , 2001, The Journal of Biological Chemistry.
[102] Rushana Azimova,et al. The channel hypothesis of Huntington’s disease , 2001, Brain Research Bulletin.
[103] D. Selkoe. Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.
[104] C. Dobson,et al. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N‐terminal domain , 2001, Protein science : a publication of the Protein Society.
[105] M. F. Perutz,et al. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats , 2001, Nature.
[106] C. Ross,et al. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. , 2001, Human molecular genetics.
[107] E. Williamson,et al. Hsp70 and Antifibrillogenic Peptides Promote Degradation and Inhibit Intracellular Aggregation of Amyloidogenic Light Chains , 2001, The Journal of cell biology.
[108] J. Bartek,et al. Order from Destruction , 2001, Science.
[109] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[110] D. Butterfield,et al. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. , 2001, Trends in molecular medicine.
[111] A. Miranker,et al. Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation. , 2001, Journal of molecular biology.
[112] M. Parker,et al. The cholesterol-dependent cytolysins. , 2001, Current topics in microbiology and immunology.
[113] J. King,et al. Frequencies of amino acid strings in globular protein sequences indicate suppression of blocks of consecutive hydrophobic residues , 2001, Protein science : a publication of the Protein Society.
[114] Mark A. Smith,et al. Induction of NADPH cytochrome P450 reductase by the Alzheimer β‐protein. Amyloid as a ‘foreign body’ , 2001, Journal of neurochemistry.
[115] A. Goldberg,et al. Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.
[116] C Capanni,et al. Folding and Aggregation Are Selectively Influenced by the Conformational Preferences of the α-Helices of Muscle Acylphosphatase* , 2001, The Journal of Biological Chemistry.
[117] R. Ellis,et al. Macromolecular crowding: an important but neglected aspect of the intracellular environment. , 2001, Current opinion in structural biology.
[118] O. Matsushita,et al. Cleavage of a C-terminal Peptide Is Essential for Heptamerization of Clostridium perfringens ε-Toxin in the Synaptosomal Membrane* , 2001, The Journal of Biological Chemistry.
[119] T. Squier,et al. Oxidative stress and protein aggregation during biological aging , 2001, Experimental Gerontology.
[120] C. Dobson. The structural basis of protein folding and its links with human disease. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[121] Juan R. Granja,et al. Antibacterial agents based on the cyclic d,l-α-peptide architecture , 2001, Nature.
[122] R. Lal,et al. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[123] I. Conlon,et al. Extracellular control of cell size , 2001, Nature Cell Biology.
[124] C. Yip,et al. Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption. , 2001, Biophysical journal.
[125] U. Schlötzer-Schrehardt,et al. Analysis of aqueous humour proteins of eyes with and without pseudoexfoliation syndrome , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.
[126] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. , 2001, Biochemistry.
[127] K. McNaught,et al. Proteasomal function is impaired in substantia nigra in Parkinson's disease , 2001, Neuroscience Letters.
[128] M. Sousa,et al. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. , 2001, The American journal of pathology.
[129] B. Kagan,et al. Pore formation by beta-2-microglobulin: A mechanism for the pathogenesis of dialysis associated amyloidosis , 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[130] M. Nakanishi,et al. A degradation signal located in the C‐terminus of p21WAF1/CIP1 is a binding site for the C8 α‐subunit of the 20S proteasome , 2001, The EMBO journal.
[131] A. Rauk,et al. The radical model of Alzheimer's disease: Specific recognition of Gly29 and Gly33 by Met35 in a β-sheet model of Aβ: An ONIOM study , 2002 .
[132] S. Ji,et al. Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation* , 2002, The Journal of Biological Chemistry.
[133] L. Tjernberg,et al. Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.
[134] H. Zoghbi,et al. Mouse and fly models of neurodegeneration. , 2002, Trends in genetics : TIG.
[135] P. Lansbury,et al. Neurodegenerative disease: Amyloid pores from pathogenic mutations , 2002, Nature.
[136] P. Wesseling,et al. Collagen XVIII: a Novel Heparan Sulfate Proteoglycan Associated with Vascular Amyloid Depositions and Senile Plaques in Alzheimer's Disease Brains , 2002, Brain pathology.
[137] R. Wetzel,et al. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. , 2002, Human Molecular Genetics.
[138] Bin Liu,et al. Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species , 2002 .
[139] Christopher M. Dobson,et al. Protein-misfolding diseases: Getting out of shape , 2002, Nature.
[140] J. Kemp,et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis , 2002, Nature.
[141] F. Hartl,et al. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[142] Fabrizio Chiti,et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[143] V. Uversky. Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.
[144] S. Lindquist,et al. Neurotoxicity and Neurodegeneration When PrP Accumulates in the Cytosol , 2002, Science.
[145] The radical model of Alzheimer's disease: specific recognition of Gly29 and Gly33 by Met35 in a beta-sheet model of Abeta: an ONIOM study. , 2002, Journal of Alzheimer's disease : JAD.
[146] S. Lindquist,et al. Hsp90 as a capacitor of phenotypic variation , 2002, Nature.
[147] W. K. Cullen,et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.
[148] R. Wetzel. Ideas of order for amyloid fibril structure. , 2002, Structure.
[149] A. Björklund,et al. Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System , 2002, The Journal of Neuroscience.
[150] C. Dobson,et al. Altered aggregation properties of mutant γ‐crystallins cause inherited cataract , 2002 .
[151] Globular amyloid deposits in the wall of the gastrointestinal tract: report of six cases , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[152] Andreas Hoenger,et al. De novo designed peptide-based amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[153] Christopher A Ross,et al. Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.
[154] G. Sobue,et al. Testosterone Reduction Prevents Phenotypic Expression in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy , 2002, Neuron.
[155] Kaushik Dutta,et al. The regions of securin and cyclin B proteins recognized by the ubiquitination machinery are natively unfolded , 2002, FEBS letters.
[156] Bin Zhang,et al. Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex: Transgenic Mice Provide Insights into Mechanisms Underlying a Common Tauopathy in an Ethnic Minority on Guam , 2002, Experimental Neurology.
[157] C. Dobson,et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.
[158] N. Hattori,et al. Effect of Wild-type or Mutant Parkin on Oxidative Damage, Nitric Oxide, Antioxidant Defenses, and the Proteasome* , 2002, The Journal of Biological Chemistry.
[159] Christopher M. Dobson,et al. The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[160] D. Czajkowsky,et al. Monomer-Monomer Interactions Drive the Prepore to Pore Conversion of a β-Barrel-forming Cholesterol-dependent Cytolysin* , 2002, The Journal of Biological Chemistry.
[161] Scott J. Hultgren,et al. Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation , 2002, Science.
[162] P. Csermely,et al. Chaperone function and chaperone overload in the aged. A preliminary analysis , 2002, Experimental Gerontology.
[163] C. Olanow,et al. Impairment of the ubiquitin‐proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures , 2002, Journal of neurochemistry.
[164] N. Bonini. Chaperoning brain degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[165] P. Lansbury,et al. Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease? , 2002, Biochemistry.
[166] R. Leapman,et al. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[167] D. Allsop,et al. Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer’s disease and Parkinson’s disease. , 2002 .
[168] S. Lehmann,et al. Oxidative stress and the prion protein in transmissible spongiform encephalopathies , 2002, Brain Research Reviews.
[169] Christopher A. Ross,et al. Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization* , 2002, The Journal of Biological Chemistry.
[170] M. Perutz,et al. Aggregation of proteins with expanded glutamine and alanine repeats of the glutamine-rich and asparagine-rich domains of Sup35 and of the amyloid β-peptide of amyloid plaques , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[171] S. Radford,et al. Crystal structure of monomeric human β-2-microglobulin reveals clues to its amyloidogenic properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[172] F. Hartl,et al. Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein , 2002, Science.
[173] B. Kagan,et al. Channel formation by serum amyloid A: a potential mechanism for amyloid pathogenesis and host defense , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[174] G. Pielak,et al. FlgM gains structure in living cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[175] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[176] Peter M. G. Munro,et al. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. , 2002, Journal of cell science.
[177] J. Kourie,et al. Ion channel formation and membrane‐linked pathologies of misfolded hydrophobic proteins: The role of dangerous unchaperoned molecules , 2002, Clinical and experimental pharmacology & physiology.
[178] P. Lansbury,et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. , 2002, Journal of molecular biology.
[179] L. Serpell,et al. Proteasomal degradation of tau protein , 2002, Journal of neurochemistry.
[180] C. Link,et al. Interaction of intracellular β amyloid peptide with chaperone proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[181] P. Lansbury,et al. Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. , 2002, Biochemistry.
[182] Christopher M Dobson,et al. Getting out of shape. , 2002, Nature.
[183] D. Flood,et al. Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition , 2002, The Journal of Neuroscience.
[184] D. Rubinsztein,et al. Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. , 2002, Human molecular genetics.
[185] J. Ávila,et al. Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases , 2002, Peptides.
[186] T. Walz,et al. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[187] P. Lansbury,et al. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. , 2002, Biochemistry.
[188] P. Moreira,et al. Effect of amyloid beta-peptide on permeability transition pore: a comparative study. , 2002, Journal of neuroscience research.
[189] D. Borchelt,et al. High Molecular Weight Complexes of Mutant Superoxide Dismutase 1: Age-Dependent and Tissue-Specific Accumulation , 2002, Neurobiology of Disease.
[190] J. Richardson,et al. Natural β-sheet proteins use negative design to avoid edge-to-edge aggregation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[191] K. Davies,et al. Atherosclerosis: another protein misfolding disease? , 2002, Trends in molecular medicine.
[192] A. Fersht,et al. CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[193] P. Moreira,et al. Effect of amyloid β‐peptide on permeability transition pore: A comparative study , 2002 .
[194] A. Macario,et al. Sick chaperones and ageing: a perspective , 2002, Ageing Research Reviews.
[195] J. Kelly,et al. Prevention of Transthyretin Amyloid Disease by Changing Protein Misfolding Energetics , 2003, Science.
[196] S. Paul,et al. Immunotherapy for Alzheimer's disease: will vaccination work? , 2003, Trends in Molecular Medicine.
[197] C. Dobson. Protein Folding and Disease: a view from the first Horizon Symposium , 2003, Nature Reviews Drug Discovery.
[198] Melissa S Kosinski-Collins,et al. In vitro unfolding, refolding, and polymerization of human γD crystallin, a protein involved in cataract formation , 2003, Protein science : a publication of the Protein Society.
[199] Carl W. Cotman,et al. Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.
[200] C. Dennis. Epigenetics and disease: Altered states , 2003, Nature.
[201] J. Kourie. Mechanisms of Amyloid β Protein-Induced Modification in Ion Transport Systems: Implications for Neurodegenerative Diseases , 2001, Cellular and Molecular Neurobiology.
[202] D. Noonan. Altered states. , 2004, Newsweek.